Fund moves

Dr Reddys Laboratories (RDY)Robeco Institutional Asset Management B.V. added to its stake +843K shares

Robeco Institutional Asset Management B.V. added to its stake in Dr Reddys Laboratories, per its Q2 2026 13F.

18M
Shares reported · +843K vs prior quarter: 0.32%
Disclosed portfolio weight: $261M
Reported value

Holdings as of: Jun 30, 2026
Filed: Jul 21, 2026

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Dr Reddys Laboratories

For Dr Reddys Laboratories, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RDY page.

How this filing works

SEC Form 13F

Other disclosures at Dr Reddys Laboratories

Everything OQRO holds on this company is on its RDY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data